d

Pharmaceutical water systems in transformation mode with advanced processes & shift towards analytics

Indian and multinational pharma companies are leading the charge by investing in digital transformation and aligning Indian operations with global standards. Essentially, pharmaceutical water systems are




d

Union Ayush secretary to inaugurate 61st Ayurveda Seminar at Kottakkal Aryavaidyasala in Kerala on November 10

The secretary of the Union Ayush Ministry, Dr Rajesh Kotecha, will inaugurate the 61st Ayurveda Seminar organized by the Kottakkal Aryavaidyasala (Kottakkal AVS) on November 10 at Kottakkal in




d

PSEB seeks qualified candidates for post of managing director at KAPL

Public Sector Enterprises Selection Board (PSEB) is seeking qualified candidates for the post of managing director at the Karnataka Antibiotics & Pharmaceuticals Limited (KAPL) in Bengaluru. The candidate will be




d

AIOCD urges DCGI to immediately stop partnership between Swiggy & PharmEasy for rapid drug delivery

Raising deep concern over the partnership between Swiggy Instamart and PharmEasy for a rapid drug delivery model, the All India Organization of Chemists and Druggists (AIOCD) has apprised the Drug Controller




d

DoP rejects Aristo Pharma's review application for its multivitamin tablets

The Department of Pharmaceuticals (DoP) has upheld the retail price fixation of National Pharmaceutical Pricing Authority (NPPA) for Mumbai─based Aristo Pharmaceuticals for its multivitamin tablets with




d

FOPE spots potential opportunities for Indian cos in Australia & ECTA seen to propel easy market access

The Federation of Pharmaceutical Entrepreneurs (FOPE) has identified potential opportunities for Indian pharmaceutical companies to expand in Australia. Further, the India─Australia Economic Cooperation and Trade




d

SEC recommends marketing approval for Dr Reddy's SPMS drug Siponimod tablets

The Subject Expert Committee (SEC), which advises the national drug regulator on approval of new drugs and clinical trials, has recommended grant of market authorisation for Dr Reddy's Laboratories' Siponimod




d

Indian health, pharma companies invited to participate in Iraq's 'Medico Expo' from Feb 5─8, 2025

The Embassy of India in Iraq has extended an invitation to Indian businesses to participate in the "Medico Expo," officially known as the Erbil International Health Exhibition. This prestigious event, set to be the




d

SEC recommends approval for MSN Laboratories' sleep disorder drug

The Subject Expert Committee (SEC), which advises the national drug regulator on matters related to approval of new drugs and medical devices and clinical trials, has recommended grant of market authorisation for




d

Indian pharma & biotech cos confident of new US President Trump's support to Indian pharma

Indian pharma and biotech companies are confident that under the new US President Donald Trump, its strengths in high quality generics manufacture and export will continue to command respect. This view is




d

ICMR announces call for CAR proposals under extramural research programme

The Indian Council of Medical Research (ICMR) has issued a call for proposals for its Centre for Advanced Research (CAR) initiative under the Extramural Research Programme, inviting experienced research teams to




d

Centre notifies rules for recruitment of medical device officers in CDSCO

In an effort to strengthen the regulatory activities for medical devices in the country, the Union health ministry has framed and finalised rules regulating the method of recruitment to various posts under the Central




d

MSMEs in confusion as govt is keeping mum on demand for extending implementation of revised Schedule M

Whilst the timeline set for adhering to the revised Schedule M of the Drugs and Cosmetics Act ends on December 31 for pharmaceutical companies with a turnover of less than Rs. 250 crore, the union ministry's




d

DGTR releases list of registered parties on anti─dumping investigation on sodium citrate imports from China

The Directorate General of Trade Remedies (DGTR), under the ministry of commerce and industry, has released a list of registered interested parties regarding the ongoing Second Sunset Review anti─dumping




d

Karnataka Ayush sector upbeat on recent amendment to renew manufacturing & loan licenses to perpetuity

The recent amendments brought by the Union Ministry of Ayush to the Drugs and Cosmetics Rules, 1945 are significant, as they introduce new regulatory requirements for the manufacturing and sale of traditional




d

Ayush and herbal products exports grow over 10 per cent in H1 FY25

Exports of Ayush and herbal products for the first six months of the current fiscal has reported a 10.34 per cent growth, as compared to an almost stagnant exports reported in the same period of previous fiscal




d

DoP releases operational guidelines for Strengthening of Medical Device Industry scheme

The Department of Pharmaceuticals (DoP) has released the operational guidelines for the newly announced central sector scheme for Strengthening of Medical Device Industry (SMDI), aiming at providing




d

Oversimplification about integration of traditional & modern treatment systems creates confusion: Dr Kotecha

Oversimplification about integration of traditional and modern treatment systems often creates confusion among the stakeholders, and nobody understands the reality of the integration and what it is meant for, said Dr.




d

DGTR issues directive for sunset review anti─dumping investigation on Aniline imports from China

The Directorate General of Trade Remedies (DGTR), under the Ministry of Commerce and Industry, has issued a notice to all interested parties involved in the sunset review of the anti─dumping investigation




d

Indian healthcare industry to invest further in computational infrastructure for data integration in patient care

The Indian healthcare industry is looking to invest further in computational infrastructure as data integration frameworks and regulatory compliance are pivotal to ensure intelligent clinical support




d

NABL to usher in accreditation insights for reference material producers in Raipur and Hyderabad

Two exclusive conferences focusing on "Reference Material (RM) Producers" organized by National Accreditation Board for Testing and Calibration Laboratories (NABL) are scheduled to be held on January 10,




d

Inter─ministerial committee calls for amendment in FSSAI Act on nutraceuticals

An inter─ministerial committee formed by the Union health ministry has recommended amendments to the Food Safety and Standards Act, 2006 and regulations on nutraceuticals and health supplements, to shift regulation of




d

Telangana DCA warns private hospitals of stern action for illegal sale of narcotic drugs

Finding regulatory violations in two private hospitals operating in the twin cities of Hyderabad and Secunderabad, the Telangana drugs control administration (DCA) has issued advisories to all the private hospitals in the state mandating strict obtainment of NDPS licence (NDPS Form II) from the DCA to purchase and sell NDPS drugs.




d

Industry hails DoP's new scheme for strengthening of medical devices industry

The centrally sponsored scheme for strengthening of medical devices industry (SMDI), launched by the Central government last week, was widely welcomed by the medical devices industry in the country.




d

NABL announces joint technical training programme with MANTRA on medical textiles testing

The National Accreditation Board for Testing and Calibration Laboratories (NABL), under the Quality Council of India (QCI), has announced a collaborative effort with Man─Made Textile Research Association (MANTRA) in Surat to deliver a specialized technical training programme on medical textiles testing.




d

Indian pharma stresses for enhanced fire safety measures and improved insurance coverage for employees

The Indian pharmaceutical industry is advocating for enhanced fire safety measures and improved insurance coverage for employees working in pharmaceutical facilities.




d

Asahi Kasei Medical launches Planova FG1 next-generation virus removal filter

Asahi Kasei Medical has launched the Planova FG1, a next-generation virus removal filter featuring higher flux for the manufacture of biotherapeutics, in October 2024.




d

Hardie Polymers celebrates 100 years

Founded in 1924 as J&G Hardie, Hardie Polymers, the Glasgow-based polymer supplier, celebrates its 100th anniversary.




d

Nvision Biomedical 3D-printed PEEK Interbody System receives FDA clearance

Nvision Biomedical Technologies and Invibio Biomaterial Solutions have announced that the FDA has granted clearance of the first 3D-Printed PEEK Interbody System made from PEEK-OPTIMA.




d

Placon announces new stock medical line of pouches and tip protectors

Placon, an innovator in the medical packaging market, announced the release of a new stock line of BargerGard TPU pouches and tip protectors.




d

What to consider with 3D printing and plastics prototyping

Robert Musselle, customer engineering manager EMEA at Protolabs shares what you need to consider with 3D printing and plastics prototyping.




d

TekniPlex Healthcare to debut strong paper for medical packaging at Pack Expo

TekniPlex Healthcare is set to unveil its strongest-ever reinforced paper for medical device packaging applications at Pack Expo 2024, 3-6 November in Chicago.




d

WITTMANN BATTENFELD presents latest technology at Compamed

WITTMANN BATTENFELD will present the latest solutions for time and cost optimisation in the production of parts with nano structures at Compamed, booth No. F03-1 in hall 8b.




d

PolyNovo to exhibit at MEDICA 2024 with Medilink UK

PolyNovo UK – a UK medical devices company specialising in the development of surgical solutions using the patented polymer technology NovoSorb will be exhibiting at MEDICA 2024.




d

The latest trends and challenges in sterilisation

James Hicks, healthcare application development and processing engineer at Syensqo explores the latest trends, challenges and solutions in sterilisation.




d

Editors letter: current regulatory landscape

Olivia Friett, editor of Medical Plastics News takes a look at the current regulatory landscape.




d

Schultz Medical to exhibit at MEDICA 2024 with Medilink UK

Schultz Medical, a single use instrument company based in Southport, Merseyside have announced they will be exhibiting at MEDICA 2024 in Germany and on the UK Pavilion in Hall 15 hosted by Medilink UK.




d

UK HealthTech on full display at ABHI UK pavilion For MEDICA 2024

The Association of British HealthTech Industries (ABHI) is excited to unveil a diverse delegation of UK HealthTech innovators at MEDICA 2024, one of the world's largest and most influential medical trade fairs.




d

Q&A: Bringing sustainability into the medical industry

Brightmark CEO Bob Powell discusses Plastics Renewal technology and how to bring sustainability into the medical industry.




d

Ampacet ProVital+ Gamma-Protect preserves polypropylene-based medical plastics during sterilisation process

Ampacet has introduced ProVital+ Gamma-Protect, a medical-grade additive designed to preserve mechanical and optical properties of polypropylene-based medical and pharmaceutical articles during gamma and e-beam sterilisation processes.




d

Accumold showcases micromoulding innovation at Compamed

Accumold, with over 40 years of experience in micromoulding technology, is set to participate at Compamed, taking place in Düsseldorf, Germany, from 11-14 November. The company will highlight its small and complex parts for medical device OEMs.




d

LFH Regulatory to attend MEDICA to provide guidance on navigating markets

Regulatory experts LFH Regulatory have announced their attendance at MEDICA 2024 to provide insights and support to healthcare innovators facing the complexities of the UK and EU markets.




d

Protecting vital medical implants with epoxies

Mike Hodgin, director of strategic applications, Meridian Electronics Division discusses enabling and protecting vital medical implants with epoxies.




d

Surgical Holdings attends MEDICA 2024

Surgical Holdings, a British manufacturer and repairer of medical devices, will return to MEDICA 2024 for the third consecutive year, focused on strengthening its partnerships across Europe and expanding its reach in key markets.




d

Syensqo to showcase portfolio of medical-grade polymers at Compamed

Syensqo, previously part of Solvay Group and a global provider of advanced performance materials and chemical solutions, is making its debut at Compamed 2024.




d

The role of surface preparation in the application of hydrophilic and hydrophobic coatings

Joe Anderson, product and promotional marketing manager at Harland, explores the role of surface preparation in the application of hydrophilic and hydrophobic coatings.




d

Gerresheimer wins Red Dot Award

Gerresheimer, an innovative system and solution provider, received a Red Dot Design Concept award for its Gx Inbeneo autoinjector platform.




d

Five steps to successful medical device development

Dr Euan McBrearty, head of commerical & innovation, Wideblue shares five steps to successful medical device development.




d

Trelleborg Medical Solutions showcases polymer-based solutions at Compamed

Trelleborg Medical Solutions showcases its comprehensive polymer-based solutions and capabilities for the medical technology and biopharmaceutical industries at Compamed 2024 in Dusseldorf from November 11 to 14, at stand F02 in hall 8A.




d

How are contract manufacturers driving sustainability?

Nick Guerin, CSP, director of environmental, health & safety at Tessy Plastics highlights how contract manufacturers are driving sustainability in the medical plastics industry.